Optimind Pharma Corp. provides psychedelic therapies in Canada. The company offers psychedelic-like therapies for the treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities through ketamine-assisted treatment and other psychedelic enhanced psychotherapy modalities. It also prescribes medical cannabis and other alternative treatments for various medical ailments through its clinics. Optimind Pharma Corp. is headquartered in Toronto, Canada.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Goodman, David

Employees

Website

optimindpharma.com

IPO Date

2022-08-04

Headquarters

40 King Street West, Suite 2400, Toronto, Ontario, M5H 3Y2, Canada

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.